Next Article in Journal
Diagnosis, Monitoring, and Management of Adverse Events From Immune Checkpoint Inhibitor Therapy
Previous Article in Journal
Immunotherapy in Hematologic Malignancies
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

A New Hope

St. Boniface General Hospital, Winnipeg, MB, Canada
Curr. Oncol. 2020, 27(s2), 41-42; https://doi.org/10.3747/co.27.6035
Submission received: 7 January 2020 / Revised: 4 February 2020 / Accepted: 10 March 2020 / Published: 1 April 2020

Abstract

Immuno-oncology uses the body’s inherent immune system to combat malignancy. […]

Share and Cite

MDPI and ACS Style

Wong, R. A New Hope. Curr. Oncol. 2020, 27, 41-42. https://doi.org/10.3747/co.27.6035

AMA Style

Wong R. A New Hope. Current Oncology. 2020; 27(s2):41-42. https://doi.org/10.3747/co.27.6035

Chicago/Turabian Style

Wong, R. 2020. "A New Hope" Current Oncology 27, no. s2: 41-42. https://doi.org/10.3747/co.27.6035

Article Metrics

Back to TopTop